

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.73299884 |
| 2 | drug catabolic process (GO:0042737) | 9.30623046 |
| 3 | glyoxylate metabolic process (GO:0046487) | 8.71431350 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 8.46558188 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 8.19198159 |
| 6 | regulation of fibrinolysis (GO:0051917) | 7.86776162 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.75972708 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.75972708 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 7.64218752 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 7.02492659 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.02492659 |
| 12 | complement activation, alternative pathway (GO:0006957) | 6.96797841 |
| 13 | regulation of protein activation cascade (GO:2000257) | 6.77535436 |
| 14 | oxidative demethylation (GO:0070989) | 6.75524453 |
| 15 | cellular glucuronidation (GO:0052695) | 6.68800145 |
| 16 | urea metabolic process (GO:0019627) | 6.48025626 |
| 17 | fibrinolysis (GO:0042730) | 6.46766522 |
| 18 | uronic acid metabolic process (GO:0006063) | 6.37308643 |
| 19 | glucuronate metabolic process (GO:0019585) | 6.37308643 |
| 20 | drug metabolic process (GO:0017144) | 6.32788460 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 6.32730556 |
| 22 | regulation of complement activation (GO:0030449) | 6.27319180 |
| 23 | bile acid biosynthetic process (GO:0006699) | 6.26745706 |
| 24 | ethanol oxidation (GO:0006069) | 6.19536503 |
| 25 | blood coagulation, intrinsic pathway (GO:0007597) | 6.04679778 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 5.92063162 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.91411536 |
| 28 | glycine metabolic process (GO:0006544) | 5.90160358 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.83894716 |
| 30 | protein carboxylation (GO:0018214) | 5.83894716 |
| 31 | phenylpropanoid metabolic process (GO:0009698) | 5.73855238 |
| 32 | negative regulation of cholesterol transport (GO:0032375) | 5.66806739 |
| 33 | negative regulation of sterol transport (GO:0032372) | 5.66806739 |
| 34 | bile acid metabolic process (GO:0008206) | 5.55654714 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 5.36924623 |
| 36 | urea cycle (GO:0000050) | 5.34296817 |
| 37 | S-adenosylmethionine metabolic process (GO:0046500) | 5.10438373 |
| 38 | ethanol metabolic process (GO:0006067) | 5.05252963 |
| 39 | bile acid and bile salt transport (GO:0015721) | 5.02417246 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.94534863 |
| 41 | regulation of plasminogen activation (GO:0010755) | 4.88377432 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.71856254 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.71856254 |
| 44 | serine family amino acid metabolic process (GO:0009069) | 4.70470846 |
| 45 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.69145235 |
| 46 | alkaloid metabolic process (GO:0009820) | 4.64119678 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.55847281 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.55847281 |
| 49 | protein activation cascade (GO:0072376) | 4.53278379 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.50293718 |
| 51 | imidazole-containing compound metabolic process (GO:0052803) | 4.29335133 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 4.28588011 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 4.28588011 |
| 54 | tryptophan catabolic process (GO:0006569) | 4.28588011 |
| 55 | negative regulation of coagulation (GO:0050819) | 4.24590368 |
| 56 | negative regulation of wound healing (GO:0061045) | 4.21659377 |
| 57 | heme transport (GO:0015886) | 4.17922057 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.14850638 |
| 59 | arginine metabolic process (GO:0006525) | 4.11880148 |
| 60 | complement activation (GO:0006956) | 4.09089581 |
| 61 | serine family amino acid biosynthetic process (GO:0009070) | 4.07854403 |
| 62 | hormone catabolic process (GO:0042447) | 4.05973238 |
| 63 | response to mercury ion (GO:0046689) | 4.05255334 |
| 64 | complement activation, classical pathway (GO:0006958) | 4.01511597 |
| 65 | regulation of humoral immune response (GO:0002920) | 3.97542666 |
| 66 | negative regulation of protein activation cascade (GO:2000258) | 3.96868186 |
| 67 | negative regulation of lipase activity (GO:0060192) | 3.96030281 |
| 68 | aromatic amino acid family metabolic process (GO:0009072) | 3.95515423 |
| 69 | phospholipid efflux (GO:0033700) | 3.93114254 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 3.91134771 |
| 71 | positive regulation of blood coagulation (GO:0030194) | 3.88940338 |
| 72 | positive regulation of hemostasis (GO:1900048) | 3.88940338 |
| 73 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.88650696 |
| 74 | amino acid salvage (GO:0043102) | 3.87781079 |
| 75 | L-methionine salvage (GO:0071267) | 3.87781079 |
| 76 | L-methionine biosynthetic process (GO:0071265) | 3.87781079 |
| 77 | acute-phase response (GO:0006953) | 3.80453872 |
| 78 | flavonoid metabolic process (GO:0009812) | 3.78449205 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 3.75664933 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.74520838 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.74520838 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.74520838 |
| 83 | opsonization (GO:0008228) | 3.74513994 |
| 84 | xenobiotic metabolic process (GO:0006805) | 3.73614748 |
| 85 | drug transmembrane transport (GO:0006855) | 3.72427653 |
| 86 | cholesterol efflux (GO:0033344) | 3.70326775 |
| 87 | tryptophan metabolic process (GO:0006568) | 3.66561231 |
| 88 | polyketide metabolic process (GO:0030638) | 3.64836399 |
| 89 | doxorubicin metabolic process (GO:0044598) | 3.64836399 |
| 90 | daunorubicin metabolic process (GO:0044597) | 3.64836399 |
| 91 | cellular amino acid catabolic process (GO:0009063) | 3.63152523 |
| 92 | cytolysis (GO:0019835) | 3.60362761 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.59119816 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59072160 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59072160 |
| 96 | intestinal cholesterol absorption (GO:0030299) | 3.58751237 |
| 97 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.58695788 |
| 98 | positive regulation of coagulation (GO:0050820) | 3.58558604 |
| 99 | sodium-independent organic anion transport (GO:0043252) | 3.58261741 |
| 100 | steroid catabolic process (GO:0006706) | 3.54683342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.02743319 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.48094009 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.59211062 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.78697344 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.51305674 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.24396591 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.99410544 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.85410475 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.71128246 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.22642738 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.51704392 |
| 12 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.27477142 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01967484 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.93625783 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.92321168 |
| 16 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.91919775 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.87644835 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.83695496 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71671821 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71547359 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68641406 |
| 22 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66985412 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57763685 |
| 24 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57561629 |
| 25 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50706815 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43023774 |
| 27 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.41402937 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35245536 |
| 29 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32175048 |
| 30 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29787915 |
| 31 | AR_20517297_ChIP-Seq_VCAP_Human | 1.27360787 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27270511 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.26147840 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24216064 |
| 35 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24099202 |
| 36 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.21065390 |
| 37 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20354769 |
| 38 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.17963292 |
| 39 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17724115 |
| 40 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.12955365 |
| 41 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12955365 |
| 42 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12234680 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12138753 |
| 44 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.10898362 |
| 45 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.10124429 |
| 46 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09238041 |
| 47 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07735924 |
| 48 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06960467 |
| 49 | NFYA_21822215_ChIP-Seq_K562_Human | 1.06595361 |
| 50 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06483419 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05139362 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04794185 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03983614 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03246596 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03242579 |
| 56 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02894527 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02478040 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01718127 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00783601 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00514838 |
| 61 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00514838 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00259979 |
| 63 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98572294 |
| 64 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.97906698 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97707796 |
| 66 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97633206 |
| 67 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.96729403 |
| 68 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.94578733 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94440583 |
| 70 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93311600 |
| 71 | NFYB_21822215_ChIP-Seq_K562_Human | 0.92455662 |
| 72 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92344016 |
| 73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92013153 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91771021 |
| 75 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90925585 |
| 76 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90520031 |
| 77 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.90004688 |
| 78 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.88330036 |
| 79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88289250 |
| 80 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.88237731 |
| 81 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.87985422 |
| 82 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.87197839 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.87197839 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86837978 |
| 85 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85565309 |
| 86 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.85500765 |
| 87 | NCOR_22424771_ChIP-Seq_293T_Human | 0.84727806 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.84309280 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84057057 |
| 90 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83327558 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82403729 |
| 92 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.82046295 |
| 93 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.81843980 |
| 94 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81670768 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81239670 |
| 96 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79801412 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.78550814 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.78272197 |
| 99 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.77998716 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.77299557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.74779806 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.12929648 |
| 3 | MP0005360_urolithiasis | 6.08591345 |
| 4 | MP0003195_calcinosis | 5.57356646 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.48320200 |
| 6 | MP0005365_abnormal_bile_salt | 5.44069934 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.78846948 |
| 8 | MP0003252_abnormal_bile_duct | 4.28624506 |
| 9 | MP0003868_abnormal_feces_composition | 3.51848647 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.21579616 |
| 11 | MP0009697_abnormal_copulation | 3.18979245 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.51382305 |
| 13 | MP0005332_abnormal_amino_acid | 2.37239027 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.19717761 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.01220459 |
| 16 | MP0001764_abnormal_homeostasis | 1.87746570 |
| 17 | MP0009840_abnormal_foam_cell | 1.75709789 |
| 18 | MP0003718_maternal_effect | 1.67836316 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.57953868 |
| 20 | MP0000609_abnormal_liver_physiology | 1.57919790 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.44923067 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.39570247 |
| 23 | MP0005395_other_phenotype | 1.39030368 |
| 24 | MP0010368_abnormal_lymphatic_system | 1.19069646 |
| 25 | MP0005408_hypopigmentation | 1.13910006 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.12582940 |
| 27 | MP0003186_abnormal_redox_activity | 1.02318705 |
| 28 | MP0005187_abnormal_penis_morphology | 1.01371880 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.01114518 |
| 30 | MP0005670_abnormal_white_adipose | 0.96956584 |
| 31 | MP0003011_delayed_dark_adaptation | 0.96348462 |
| 32 | MP0008872_abnormal_physiological_respon | 0.94383760 |
| 33 | MP0004043_abnormal_pH_regulation | 0.94044712 |
| 34 | MP0000598_abnormal_liver_morphology | 0.92862616 |
| 35 | MP0009053_abnormal_anal_canal | 0.92698615 |
| 36 | MP0006292_abnormal_olfactory_placode | 0.89731430 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 0.89354918 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.89188482 |
| 39 | MP0003879_abnormal_hair_cell | 0.88522341 |
| 40 | MP0002168_other_aberrant_phenotype | 0.87706532 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82910943 |
| 42 | MP0001661_extended_life_span | 0.82598480 |
| 43 | MP0002132_abnormal_respiratory_system | 0.80613801 |
| 44 | MP0005647_abnormal_sex_gland | 0.77564936 |
| 45 | MP0009642_abnormal_blood_homeostasis | 0.77219236 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.76976726 |
| 47 | MP0002282_abnormal_trachea_morphology | 0.70194528 |
| 48 | MP0009763_increased_sensitivity_to | 0.66189881 |
| 49 | MP0005646_abnormal_pituitary_gland | 0.66097118 |
| 50 | MP0005266_abnormal_metabolism | 0.63112252 |
| 51 | MP0001756_abnormal_urination | 0.57256125 |
| 52 | MP0003638_abnormal_response/metabolism_ | 0.56408616 |
| 53 | MP0009764_decreased_sensitivity_to | 0.56396282 |
| 54 | MP0005535_abnormal_body_temperature | 0.54666963 |
| 55 | MP0005464_abnormal_platelet_physiology | 0.54398406 |
| 56 | MP0000566_synostosis | 0.54362247 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 0.53839721 |
| 58 | MP0001915_intracranial_hemorrhage | 0.52605511 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.52397112 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.49640197 |
| 61 | MP0008469_abnormal_protein_level | 0.49422534 |
| 62 | MP0002971_abnormal_brown_adipose | 0.48725407 |
| 63 | MP0002928_abnormal_bile_duct | 0.46984409 |
| 64 | MP0002090_abnormal_vision | 0.46141814 |
| 65 | MP0002249_abnormal_larynx_morphology | 0.42175615 |
| 66 | MP0008874_decreased_physiological_sensi | 0.41735761 |
| 67 | MP0002234_abnormal_pharynx_morphology | 0.40196951 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 0.39667953 |
| 69 | MP0005334_abnormal_fat_pad | 0.39088472 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.37447413 |
| 71 | MP0003699_abnormal_female_reproductive | 0.37133626 |
| 72 | MP0004142_abnormal_muscle_tone | 0.34786044 |
| 73 | MP0000604_amyloidosis | 0.32663228 |
| 74 | MP0005410_abnormal_fertilization | 0.32461837 |
| 75 | MP0001984_abnormal_olfaction | 0.32206807 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.30716263 |
| 77 | MP0003959_abnormal_lean_body | 0.30641114 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.30304846 |
| 79 | MP0008877_abnormal_DNA_methylation | 0.30141314 |
| 80 | MP0003953_abnormal_hormone_level | 0.29794787 |
| 81 | MP0003941_abnormal_skin_development | 0.29629598 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 0.29582083 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.29331200 |
| 84 | MP0005451_abnormal_body_composition | 0.25605579 |
| 85 | MP0001929_abnormal_gametogenesis | 0.25518660 |
| 86 | MP0001293_anophthalmia | 0.25357638 |
| 87 | MP0008873_increased_physiological_sensi | 0.24551246 |
| 88 | MP0002736_abnormal_nociception_after | 0.24394594 |
| 89 | MP0003890_abnormal_embryonic-extraembry | 0.23803953 |
| 90 | MP0005499_abnormal_olfactory_system | 0.23495906 |
| 91 | MP0005394_taste/olfaction_phenotype | 0.23495906 |
| 92 | MP0003690_abnormal_glial_cell | 0.23207845 |
| 93 | MP0002161_abnormal_fertility/fecundity | 0.22454429 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.21237530 |
| 95 | MP0002069_abnormal_eating/drinking_beha | 0.21015789 |
| 96 | MP0001324_abnormal_eye_pigmentation | 0.20714463 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.20569661 |
| 98 | MP0002697_abnormal_eye_size | 0.19814084 |
| 99 | MP0000653_abnormal_sex_gland | 0.19748162 |
| 100 | MP0005448_abnormal_energy_balance | 0.19259842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.18757852 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.61787750 |
| 3 | Complement deficiency (HP:0004431) | 7.97669032 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.89748770 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.45396609 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 6.50044257 |
| 7 | Abnormality of complement system (HP:0005339) | 6.24545281 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.66685970 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.63072844 |
| 10 | Joint hemorrhage (HP:0005261) | 5.62573168 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.99024091 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.84283343 |
| 13 | Xanthomatosis (HP:0000991) | 4.36642072 |
| 14 | Hyperglycinemia (HP:0002154) | 4.26420883 |
| 15 | Glomerulonephritis (HP:0000099) | 4.20689216 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10605246 |
| 17 | Spontaneous abortion (HP:0005268) | 4.09161777 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.08965540 |
| 19 | Generalized aminoaciduria (HP:0002909) | 4.01860159 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79524281 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.78609777 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.67252505 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.67252505 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.53102234 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.48302245 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.44870047 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43415490 |
| 28 | Hyperglycinuria (HP:0003108) | 3.39759448 |
| 29 | Fat malabsorption (HP:0002630) | 3.38519898 |
| 30 | Abnormality of serum amino acid levels (HP:0003112) | 3.31231669 |
| 31 | Hyperammonemia (HP:0001987) | 3.27544644 |
| 32 | Rickets (HP:0002748) | 3.24652808 |
| 33 | Delayed CNS myelination (HP:0002188) | 3.20208827 |
| 34 | Nephritis (HP:0000123) | 3.19371693 |
| 35 | Fair hair (HP:0002286) | 3.17067568 |
| 36 | Osteomalacia (HP:0002749) | 3.15691477 |
| 37 | Epidermoid cyst (HP:0200040) | 2.80981617 |
| 38 | Steatorrhea (HP:0002570) | 2.80849391 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.80019322 |
| 40 | Reduced antithrombin III activity (HP:0001976) | 2.76155322 |
| 41 | Cholecystitis (HP:0001082) | 2.73985628 |
| 42 | Abnormal gallbladder physiology (HP:0012438) | 2.73985628 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.69846255 |
| 44 | Gingival bleeding (HP:0000225) | 2.61204171 |
| 45 | Abnormality of urine glucose concentration (HP:0011016) | 2.51945902 |
| 46 | Glycosuria (HP:0003076) | 2.51945902 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.50958107 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.50081144 |
| 49 | Hyperphosphaturia (HP:0003109) | 2.49715716 |
| 50 | Abnormal biliary tract physiology (HP:0012439) | 2.45043747 |
| 51 | Bile duct proliferation (HP:0001408) | 2.45043747 |
| 52 | Neonatal hypoglycemia (HP:0001998) | 2.44862852 |
| 53 | Hypophosphatemic rickets (HP:0004912) | 2.41111163 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.40146515 |
| 55 | Bifid scrotum (HP:0000048) | 2.38218667 |
| 56 | Vascular calcification (HP:0004934) | 2.36427508 |
| 57 | Abnormality of vitamin metabolism (HP:0100508) | 2.34601893 |
| 58 | Metabolic acidosis (HP:0001942) | 2.33620743 |
| 59 | Menorrhagia (HP:0000132) | 2.31467828 |
| 60 | Ketosis (HP:0001946) | 2.26753358 |
| 61 | Generalized hypopigmentation of hair (HP:0011358) | 2.18997233 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.17818895 |
| 63 | Increased mean platelet volume (HP:0011877) | 2.16117772 |
| 64 | Alkalosis (HP:0001948) | 2.15437707 |
| 65 | Thrombophlebitis (HP:0004418) | 2.13985315 |
| 66 | Purpura (HP:0000979) | 2.12992372 |
| 67 | Hemorrhage of the eye (HP:0011885) | 2.12420029 |
| 68 | Elevated alkaline phosphatase (HP:0003155) | 2.10184917 |
| 69 | Irritability (HP:0000737) | 2.08083521 |
| 70 | Abnormal urine phosphate concentration (HP:0012599) | 2.07040361 |
| 71 | Cholelithiasis (HP:0001081) | 2.02361958 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.00474233 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.0304127 |
| 74 | Cardiovascular calcification (HP:0011915) | 1.99184226 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 1.97165863 |
| 76 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93611316 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 1.92815763 |
| 78 | Mitral stenosis (HP:0001718) | 1.92048085 |
| 79 | Hepatocellular carcinoma (HP:0001402) | 1.91341000 |
| 80 | Azoospermia (HP:0000027) | 1.90178522 |
| 81 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89331477 |
| 82 | Abnormal platelet volume (HP:0011876) | 1.87012517 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 1.86398312 |
| 84 | Lethargy (HP:0001254) | 1.85836977 |
| 85 | Pulmonary embolism (HP:0002204) | 1.85351206 |
| 86 | Arthropathy (HP:0003040) | 1.82389992 |
| 87 | Poikilocytosis (HP:0004447) | 1.78600161 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 1.74501983 |
| 89 | Hypoglycemic coma (HP:0001325) | 1.64717088 |
| 90 | Gout (HP:0001997) | 1.63965873 |
| 91 | Enlarged kidneys (HP:0000105) | 1.61241917 |
| 92 | Abnormal platelet function (HP:0011869) | 1.55529406 |
| 93 | Impaired platelet aggregation (HP:0003540) | 1.55529406 |
| 94 | Cerebral edema (HP:0002181) | 1.54882106 |
| 95 | Increased circulating renin level (HP:0000848) | 1.53124739 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.51854986 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.51452553 |
| 98 | Increased serum pyruvate (HP:0003542) | 1.50475216 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 1.48316418 |
| 100 | Impulsivity (HP:0100710) | 1.47106591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 6.99453154 |
| 2 | PIK3CG | 3.29084127 |
| 3 | OXSR1 | 2.98700628 |
| 4 | FRK | 2.85408262 |
| 5 | BRSK2 | 2.44776047 |
| 6 | TNK2 | 2.34036863 |
| 7 | AKT3 | 2.31517803 |
| 8 | TRIM28 | 2.25157569 |
| 9 | NUAK1 | 2.22127897 |
| 10 | EIF2AK3 | 2.15927721 |
| 11 | TAOK3 | 2.02611452 |
| 12 | ZAK | 2.00851038 |
| 13 | BCKDK | 1.91780788 |
| 14 | FER | 1.87323874 |
| 15 | INSRR | 1.69305588 |
| 16 | CASK | 1.63615363 |
| 17 | BMPR1B | 1.59482624 |
| 18 | MAP4K2 | 1.57017831 |
| 19 | EIF2AK1 | 1.52030339 |
| 20 | GRK1 | 1.48682682 |
| 21 | MAPK13 | 1.39623999 |
| 22 | STK39 | 1.34691143 |
| 23 | PRKACG | 1.34589271 |
| 24 | MST4 | 1.32238840 |
| 25 | PRKCG | 1.30827476 |
| 26 | STK38L | 1.30318823 |
| 27 | SGK2 | 1.28376658 |
| 28 | PAK3 | 1.22794369 |
| 29 | PRKD3 | 1.22065140 |
| 30 | PINK1 | 1.20708200 |
| 31 | BCR | 1.18270526 |
| 32 | PIK3CA | 1.17892903 |
| 33 | EPHA4 | 1.13640916 |
| 34 | NTRK3 | 1.13167355 |
| 35 | LATS1 | 1.12000651 |
| 36 | ACVR1B | 1.11502491 |
| 37 | NEK1 | 1.10020991 |
| 38 | CSNK1G1 | 1.05309053 |
| 39 | CDC7 | 1.04627861 |
| 40 | PRKAA2 | 1.04226968 |
| 41 | CAMK1D | 1.03009613 |
| 42 | TTK | 1.01110931 |
| 43 | MAP3K4 | 1.00076705 |
| 44 | MYLK | 0.98305996 |
| 45 | EPHA3 | 0.96007394 |
| 46 | NLK | 0.95725190 |
| 47 | CAMK1G | 0.94650375 |
| 48 | TNIK | 0.94496302 |
| 49 | PBK | 0.94116023 |
| 50 | DYRK2 | 0.88459267 |
| 51 | PRKCZ | 0.87820666 |
| 52 | IGF1R | 0.87305583 |
| 53 | ERBB3 | 0.86848475 |
| 54 | SGK223 | 0.85708501 |
| 55 | SGK494 | 0.85708501 |
| 56 | CSNK1D | 0.85374705 |
| 57 | WNK4 | 0.84984695 |
| 58 | MAP3K12 | 0.84289005 |
| 59 | NEK9 | 0.82883652 |
| 60 | PRKG1 | 0.82368407 |
| 61 | MAP3K5 | 0.79130079 |
| 62 | WEE1 | 0.77018200 |
| 63 | ADRBK2 | 0.76907788 |
| 64 | PRKACA | 0.73546405 |
| 65 | MAP2K4 | 0.72681304 |
| 66 | CSNK1E | 0.69862820 |
| 67 | VRK1 | 0.65905310 |
| 68 | PRKAA1 | 0.64294092 |
| 69 | PLK3 | 0.63585032 |
| 70 | ARAF | 0.62371790 |
| 71 | PRKCE | 0.61325614 |
| 72 | PRKCI | 0.59965593 |
| 73 | SGK3 | 0.58077441 |
| 74 | CSNK1G3 | 0.57226638 |
| 75 | MAP3K9 | 0.57119077 |
| 76 | PLK1 | 0.54740033 |
| 77 | NEK6 | 0.52853813 |
| 78 | TIE1 | 0.52463442 |
| 79 | CSNK1A1 | 0.50529962 |
| 80 | CDK9 | 0.50401803 |
| 81 | AURKA | 0.50336582 |
| 82 | PLK4 | 0.48667925 |
| 83 | CSNK1A1L | 0.47347082 |
| 84 | PRKCB | 0.47159691 |
| 85 | CDK7 | 0.46993286 |
| 86 | PRKCA | 0.46766522 |
| 87 | ATM | 0.43891892 |
| 88 | CSNK1G2 | 0.43689173 |
| 89 | PRKACB | 0.43218954 |
| 90 | ERBB2 | 0.43106334 |
| 91 | STK3 | 0.42735562 |
| 92 | BRSK1 | 0.40578230 |
| 93 | STK16 | 0.37519109 |
| 94 | TAF1 | 0.35395750 |
| 95 | MAP2K7 | 0.34655490 |
| 96 | MET | 0.33392329 |
| 97 | PKN1 | 0.32103674 |
| 98 | MARK1 | 0.31825729 |
| 99 | RPS6KA3 | 0.31739205 |
| 100 | MELK | 0.31415732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.69002475 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.05590077 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.76773955 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49394275 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.38634619 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.37531513 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.26909547 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.93112360 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.87138801 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.83943232 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.73136957 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.64722729 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.53552128 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39089618 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38472375 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.33658764 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24773709 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24456092 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.06555279 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93179810 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.87565868 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82483523 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81029146 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.77095985 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.69306223 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56055851 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.51971043 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45722058 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44671386 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42188264 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.41725319 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40210764 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.39693321 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.32488254 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30819468 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.22805248 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22392848 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21651329 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11816420 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08861253 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05277353 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00727522 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92848652 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86926131 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85988738 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85035487 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83024509 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80599680 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80109703 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.73940757 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72239652 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.70479463 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.70254792 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67303544 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56042729 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49305278 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49204777 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48010575 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47020788 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36946994 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35930007 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35409369 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34370566 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28117899 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21083998 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19320912 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17505253 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16222863 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.12282055 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08035129 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.07227291 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.06770225 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06638287 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.05150414 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.00378893 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | -0.2381909 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | -0.2271378 |
| 78 | Base excision repair_Homo sapiens_hsa03410 | -0.2197877 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | -0.2038480 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1977997 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | -0.1886756 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | -0.1879626 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1798096 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | -0.1530434 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.1415047 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1407291 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1333058 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1220028 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1191743 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1012486 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0934233 |
| 92 | Mismatch repair_Homo sapiens_hsa03430 | -0.0731638 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0655878 |
| 94 | Phototransduction_Homo sapiens_hsa04744 | -0.0647704 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0492261 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | -0.0280186 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0097811 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0090735 |
| 99 | Pertussis_Homo sapiens_hsa05133 | -0.0055556 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0043731 |

